Search Results - "Thubert, J."

  • Showing 1 - 2 results of 2
Refine Results
  1. 1

    Microbiologic contamination study of nebulizers after aerosol therapy in patients with cystic fibrosis by Vassal, S., Taamma, R., Marty, N., Sardet, A., d’Athis, P., Brémont, F., Dalphin, M.L., Plésiat, P., Rault, G., Thubert, J., Dominique, S., Lemeland, J.F., Derelle, J., Blech, M.F., Roussey, M., Perrin, M., Sautegeau, A.

    Published in American journal of infection control (01-10-2000)
    “…Background: To evaluate the contamination of delivery systems after an aerosol therapy session in patients with cystic fibrosis who have chronic Pseudomonas…”
    Get full text
    Journal Article
  2. 2

    Inhaled therapies, azithromycin and Mycobacterium abscessus in cystic fibrosis patients by CATHERINOT, Emilie, ROUX, Anne-Laure, GAILLARD, Jean-Louis, VIBET, Marie-Anne, BELLIS, Gil, LEMONNIER, Lydie, LE ROUX, Evelyne, BERNEDE-BAUDUIN, Claire, LE BOURGEOIS, Muriel, HERRMANN, Jean-Louis, GUILLEMOT, Didier

    Published in The European respiratory journal (01-05-2013)
    “…Cystic fibrosis (CF) patients are at particularly high risk of developing lung disease caused by Mycobacterium abscessus complex (MABSC). Over the last 10…”
    Get full text
    Journal Article